Evolva

Evolva is a Switzerland-based biotechnology company that develops and commercializes products such as nature-based ingredients and flavors for the pharmaceutical industry.

Business Model:

Revenue: $10.8M

Employees: 51-200

Detailed Evolva Information

Geographic Data

Evolva headquarters map

Address: Duggingerstrasse 23

City: Reinach

State: basel-country

Zip: CH-4153

Country: CH

Financial Info

Stage:

post ipo equity

Raised Last:

$7M

Raised Total:

$121M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Evolva is a Switzerland-based biotechnology company that develops and commercializes products such as nature-based ingredients and flavors for the pharmaceutical industry.

Contact Phone:

Contact Email:

Evolva went public on 12/1/2009 on the SIX Swiss Exchange

Listed Exchange:
SIX Swiss Exchange

IPO Date:
12/1/2009

Ticker Symbol:
EVE

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
1/2008 Grant $5M
10/2022 Grant $540k Centers for Disease Control and Prevention
11/2017 Post-IPO Equity $86.1M
5/2022 Private Placement $6.5M
5/2021 Post-IPO Debt $22.2M Nice & Green
12/2020 Post-IPO Debt $13.3M Nice & Green
5/2022 Post-IPO Equity $6.5M
12/2009 Post-IPO Equity 9 $27.5M Swisscom Ventures
Novartis Venture Fund
Aravis Ventures
Wellington Partners
Auriga Partners
VINCI CAPITAL
Entrepreneurs Fund
Dansk Innovation
BioMedPartners
Swisscom Ventures
Novartis Venture Fund
Aravis Ventures
Wellington Partners
Auriga Partners
VINCI CAPITAL
Entrepreneurs Fund
Dansk Innovation
10/2022 Grant 1 $540k Centers for Disease Control and Prevention
Centers for Disease Control and Prevention
8/2004 Series A 4 $14.8M Aravis Ventures
Yamanouchi Venture Capital
Novartis Venture Fund
Dansk Innovation
Aravis Ventures
10/2009 Series B 8 $27.8M Aravis Ventures
Astellas Venture Management
Auriga Partners
BioMedPartners
Dansk Innovation
Novartis Venture Fund
VINCI CAPITAL
Wellington Partners
Aravis Ventures
12/2020 Post-IPO Equity 1 $13.5M Nice &a; Green SA
Nice &a; Green SA
Nice &a; Green SA
Nice &a; Green SA
12/2006 Series A 5 $10.3M Yamanouchi Venture Capital
Novartis Venture Fund
Dansk Innovation
Aravis Ventures
APIDC Venture Capital
3/2005 Series A 4 $2.6M Yamanouchi Venture Capital
Novartis Venture Fund
Dansk Innovation
APIDC Venture Capital
12/2021 Post-IPO Debt 1 $13.1M Nice &a; Green SA
Nice &a; Green SA
Nice &a; Green SA
Nice &a; Green SA
Announced Date Name Price
11/2014 Allylix
8/2014 Prosarix
11/2012 Fluxome
7/2011 Abunda Nutrition

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research